SGOT and SGPT tests abnormality in the hospitalized women patients with covid۱۹

The corona virus disease ۲۰۱۹ (COVID-۱۹) outbreak, caused by severe acute respiratory syndrome corona virus ۲ (SARS-CoV-۲), is a global public health issue which has profound effects on most aspects of societal well-being, including physical and mental health. A plethora of studies globally have suggested the existence of a sex disparity in the severity and outcome of COVID-۱۹ patients, mainly due to mechanisms of virus infection, immune response to the virus, development of systemic inflammation, and consequent systemic complications, particularly thromboembolism. Descriptive reports have consistently found that in comparison to women's, men are at an increased risk of mortality from COVID-۱۹To optimize care for COVID-۱۹ patients, laboratory and therapeutic studies should include sex-specific design and analyses[۱-۳]. The Serum Glutamic Oxaloacetic Transaminase (SGOT) and SGPT (Serum Glutamic Pyruvate Transaminase) rate is significantly elevated in COVID-۱۹ patients. This study aims to analyze SGOT and SGPT in covid۱۹ women patients and comprise with men's group [۴-۶] .

کلیدواژه ها:

Covid۱۹ ، SGOT ، SGPT ، AST ، ALT ،